Albendazole Nanocrystals With Improved Pharmacokinetic Performance in Mice

References

• Zhou Y Du J Wang L Wang Y . State of the art of nanocrystals technology for delivery of poorly soluble drugs. J. Nanoparticle Res.18 (9), 1–22 (2016).
   Web of Science ®Google Scholar
• Keck CM Müller RH . Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. Eur. J. Pharm. Biopharm.62 (1), 3–16 (2006).
   PubMed Web of Science ®Google Scholar
• Müller RH Gohla S Keck CM . State of the art of nanocrystals–special features, production, nanotoxicology aspects and intracellular delivery. Eur. J. Pharm. Biopharm.78 (1), 1–9 (2011).
   PubMed Web of Science ®Google Scholar
• Shegokar R Müller RH . Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives. Int. J. Pharm.399 (2), 129–139 (2010).
   PubMedGoogle Scholar
• Mohana K Srivalli R Mishra B . Drug nanocrystals: a way toward scale-up. Saudi Pharm. J.24 (4), 386–404 (2016).
   PubMed Web of Science ®Google Scholar
• Lacey E . Mode of action of benzimidazoles. Parasitol. Today6 (4), 112–115 (1990).
   PubMedGoogle Scholar
• Pensel PE Castro S Allemandi D Bruni S Sanchez Palma SD Elissondo MC . Enhanced chemoprophylactic and clinical efficacy of albendazole formulated as solid dispersions in experimental cystic echinococcosis. Vet. Parasitol.203 (1), 80–86 (2014).
   PubMed Web of Science ®Google Scholar
• Moreno-Esparza R Jung H Medina L García L Fuentes I . Absorption studies of albendazole and some physicochemical properties of the drug and its metabolite albendazole sulphoxide. J. Pharm. Pharmacol.50 (1), 43–48 (1998).
   PubMed Web of Science ®Google Scholar
• Abulaihaiti M Wu X Qiao L et al. Efficacy of albendazole–chitosan microsphere-based treatment for alveolar echinococcosis in mice. PLoNegl S. Trop. Dis.9 (9), e0003950 (2015).
   PubMed Web of Science ®Google Scholar
• Mingjie W Shuhua X Junjie C et al. Albendazole–soybean oil emulsion for the treatment of human cystic echinococcosis: evaluation of bioavailability and bioequivalence. Acta Trop.83 (2), 177–181 (2002).
   PubMed Web of Science ®Google Scholar
• Priotti J Codina AV Leonardi D et al. Albendazole microcrystal formulations based on chitosan and cellulose derivatives: physicochemical characterisation and in vitro parasiticidal activity in Trichinella spiralis adult worms. APharmSciTech APS18 (4), 947–956 (2017).
   PubMed Web of Science ®Google Scholar
• Castro SG Sanchez Bruni SF Urbizu LP et al. Enhanced dissolution and systemic availability of albendazole formulated as solid dispersions. Pharm. Dev. Technol.18 (2), 1–9 (2012).
   Web of Science ®Google Scholar
• Wen H New RR Muhmut M et al. Pharmacology and efficacy of liposome-entrapped albendazole in experimental secondary alveolar echinococcosis and effect of co-administration with cimetidine. Parasitology113 (2), 111–121 (1996).
   PubMedGoogle Scholar
• Palomares-Alonso F Rivas C Bernad-Bernad MJ et al. Two novel ternary albendazole–cyclodextrin–polymer systems: dissolution. bioavailability and efficacy against Taenia crassiceps cysts. Acta Trop.113, 56–60 (2010).
   PubMed Web of Science ®Google Scholar
• Vogt M Kunath K Dressman JB . Dissolution improvement of four poorly water soluble drugs by co-grinding with commonly used excipients. Eur. J. Pharm. Biopharm.68, 330–337 (2008).
   PubMed Web of Science ®Google Scholar
• Naseri M Akbarzadeh A Spotin A . Scolicidal and apoptotic activities of albendazole sulphoxide and albendazole sulphoxide-loaded PLGA-PEG as a novel nanopolymeric particle against Echinococcus granulosus protoscoleces. Parasitol. Res.115 (12), 4595–4603 (2016).
   PubMed Web of Science ®Google Scholar
• Kang BS Choi JS Lee SE et al. Enhancing the in vitro anticancer activity of albendazole incorporated into chitosan-coated PLGA nanoparticles. Carbohydr Polym.159, 39–47 (2016).
   PubMed Web of Science ®Google Scholar
• Kudtarkar SKA Shinde U Bharkad GP . Solid lipid nanoparticles of albendazole for treatment of Toxocara canis infection: in vivo efficacy studies. Nanosci. Nanotechnol. Asia7 (2), 80–91 (2017).
   Google Scholar
• Jelowdar A Rafiei A Abbaspour MR Rahdar M . Efficacy of combined albendazol and praziquntel and their loaded solid lipid nanoparticles components in chemoprophylaxis of experimental hydatidosis. Asian Pac. J. Trop. Biomed.7 (6), 549–554 (2017).
   Web of Science ®Google Scholar
• Paredes AJ Llabot JM Bruni S Sánchez Allemandi D Palma SD . Self-dispersible nanocrystals of albendazole produced by high pressure homogenization and spray-drying. Drug Dev. Ind. Pharm.42 (10), 1564–1570 (2016).
   PubMed Web of Science ®Google Scholar
• Sánchez SF Alvarez LI Lanusse CE . Nutritional condition affects the disposition kinetics of albendazole in cattle. Xenobiotica26 (3), 307–319 (1996).
   PubMed Web of Science ®Google Scholar
• Gibaldi M Perrier D . Pharmacokinetics (2nd Edition). Marcel Dekker, Inc., NY, USA (1982).
   Google Scholar
• Di Rienzo JA Casanoves F Balzarini MG Gonzalez L Tablada M Robledo CW . InfoStat. Universidad Nacional de Córdoba. Córdoba, Argentina (2016).
   Google Scholar
• Mauludin R Müller RH Keck CM . Development of an oral rutin nanocrystal formulation. Int. J. Pharm.370, 202–209 (2009).
   PubMed Web of Science ®Google Scholar
• Dib A Palma S Suárez G et al. Albendazole sulphoxide kinetic disposition after treatment with different formulations in dogs. J. Vet. Pharmacol. Ther.34 (2), 136–141 (2011).
   PubMed Web of Science ®Google Scholar
• Sanchez Bruni SF Jones DG McKellar QA . Pharmacological approaches towards rationalizing the use of endoparasitic drugs in small animals. J. Vet. Pharmacol. Therap.29, 443–457 (2006).
   PubMed Web of Science ®Google Scholar
• Gao L Liu G Ma J Wang X Zhou L Li X . Drug nanocrystals: in vivo performances. J. Control. Rel.160 (3), 418–430 (2012).
   PubMed Web of Science ®Google Scholar
• LSCastro EPW Kviecinski MR Ourique F et al. Albendazole as a promising molecule for tumour control. Redox Biol.10, 90–99 (2016).
   PubMed Web of Science ®Google Scholar